Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bertilsson

Showing results (181-190 of 263) with videos related to

Pageof 27
Sort By:
Acta Psychiatrica Scandinavica|March 1, 1985
Homicide, suicide and CSF 5-HIAAL Lidberg, J R Tuck, M Asberg, et al.
Archives of General Psychiatry|October 1, 1987
Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorderA Wägner, A Aberg-Wistedt, M Asberg, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotypeL Bertilsson, T K Henthorn, E Sanz, et al.
European Journal of Clinical Pharmacology|July 6, 2000
Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatoninC von Bahr, C Ursing, N Yasui, et al.
Fundamental & Clinical Pharmacology|January 8, 2000
Stereospecific analysis of omeprazole supports artemisinin as a potent inducer of CYP2C19K Mihara, U S Svensson, G Tybring, et al.
Clinical Pharmacology and Therapeutics|September 1, 1986
Disposition of single oral doses of E-10-hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effectsL Bertilsson, C Nordin, K Otani, et al.
The Journal of Biological Chemistry|August 22, 2001
Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4K Bodin, L Bretillon, Y Aden, et al.
Pharmacogenetics|July 27, 2001
Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activityA Wennerholm, I Johansson, M Hidestrand, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphismK Brøsen, R Klysner, L F Gram, et al.
Lancet (London, England)|March 11, 1989
Debrisoquine hydroxylation polymorphism and personalityL Bertilsson, C Alm, C De Las Carreras, et al.
Pageof 27

Showing results (181-190 of 263) with videos related to

Sort By:
Pageof 27
Acta Psychiatrica Scandinavica|March 1, 1985
Homicide, suicide and CSF 5-HIAAL Lidberg, J R Tuck, M Asberg, et al.
Archives of General Psychiatry|October 1, 1987
Effects of antidepressant treatments on platelet tritiated imipramine binding in major depressive disorderA Wägner, A Aberg-Wistedt, M Asberg, et al.
Clinical Pharmacology and Therapeutics|April 1, 1989
Importance of genetic factors in the regulation of diazepam metabolism: relationship to S-mephenytoin, but not debrisoquin, hydroxylation phenotypeL Bertilsson, T K Henthorn, E Sanz, et al.
European Journal of Clinical Pharmacology|July 6, 2000
Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatoninC von Bahr, C Ursing, N Yasui, et al.
Fundamental & Clinical Pharmacology|January 8, 2000
Stereospecific analysis of omeprazole supports artemisinin as a potent inducer of CYP2C19K Mihara, U S Svensson, G Tybring, et al.
Clinical Pharmacology and Therapeutics|September 1, 1986
Disposition of single oral doses of E-10-hydroxynortriptyline in healthy subjects, with some observations on pharmacodynamic effectsL Bertilsson, C Nordin, K Otani, et al.
The Journal of Biological Chemistry|August 22, 2001
Antiepileptic drugs increase plasma levels of 4beta-hydroxycholesterol in humans: evidence for involvement of cytochrome p450 3A4K Bodin, L Bretillon, Y Aden, et al.
Pharmacogenetics|July 27, 2001
Characterization of the CYP2D6*29 allele commonly present in a black Tanzanian population causing reduced catalytic activityA Wennerholm, I Johansson, M Hidestrand, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphismK Brøsen, R Klysner, L F Gram, et al.
Lancet (London, England)|March 11, 1989
Debrisoquine hydroxylation polymorphism and personalityL Bertilsson, C Alm, C De Las Carreras, et al.
Pageof 27